MetaADEDB 2.0 @ LMMD
Alprostadil
(GMVPRGQOIOIIMI-DWKJAMRDSA-N)
Structure
SMILES
CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O
Type(s)
Approved; Investigational
ATC code(s)
C01EA01; G04BE01
Molecular Formula:
C20H34O5
Molecular Weight:
354.481
Log P:
3.4751
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
3
TPSA:
94.83
CAS Number(s):
745-65-3; 119314-69-1
Synonym(s)
1.
Alprostadil
2.
PGE1
3.
Prostaglandin E1
4.
Caverject
5.
Edex
6.
Lipo-PGE1
7.
Minprog
8.
Muse
9.
PGE1alpha
10.
Prostaglandin E1alpha
11.
Prostavasin
12.
Prostin VR
13.
Prostine VR
14.
Sugiran
15.
Vasaprostan
16.
Viridal
17.
Lipo PGE1
External Link(s)
MeSHD000527
PubChem Compound5280723
149351
BindingDB50101853
ChEBI15544
CHEMBLCHEMBL495
DrugBankDB00770
DrugCentral138
IUPHAR/BPS Guide to PHARMACOLOGY1882
KEGGcpd:C04741
dr:D00180
Therapeutic Target DatabaseD0I4DQ
D0N2EF
ZINC3813088
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 360
Canada Vigilance: 68		Canada Vigilance
OFFSIDES
US FAERS
2Product quality issueFAERS: 62
Canada Vigilance: 1		Canada Vigilance
OFFSIDES
US FAERS
3Erection increasedFAERS: 61
Canada Vigilance: 2		Canada Vigilance
OFFSIDES
US FAERS
4Device malfunctionFAERS: 27OFFSIDES
US FAERS
5HypotensionFAERS: 27
Canada Vigilance: 3

View details

1183588
1288905
1425618
1433870
1545507
1547050
1551156
1551157
1560571
1608152
1608154
1613947
1663172
1942503
2306970
2325248
2384952
7200736
7202062
7815696
8015154
8022855
8155447
8302922
8315791
8350464
8433498
8468782
8818092
8910175
9071102
9088814
9121395
9195357
9253574
9369049
9603592
9818109
10470753
10624637
11090726
11224012
11772822
15236040
15278582
15278665
15278816
15966603
 		CTD
Canada Vigilance
US FAERS
6Injection site painFAERS: 26
Canada Vigilance: 4		Canada Vigilance
US FAERS
7PainFAERS: 251404654
9121395		CTD
OFFSIDES
US FAERS
8PriapismFAERS: 22
Canada Vigilance: 3

View details

1719248
1769856
2310934
3045341
7713130
7824478
8851852
9121395
9806184
10098949
 		CTD
OFFSIDES
Canada Vigilance
US FAERS
9Drug effect incompleteFAERS: 20US FAERS
10Erectile dysfunctionFAERS: 20
Canada Vigilance: 2

View details

1288824
1296038
1769856
1875494
1984099
2218240
2310934
2686740
3045341
7496445
7571200
7714974
7735362
7771004
7824478
7966797
8072075
8479015
8821692
8851852
8927414
9121395
9138057
9288633
9607891
9610580
9738294
9806184
10098948
10098949
10736486
12058249
18173768
 		CTD
Canada Vigilance
US FAERS
11Incorrect dose administeredFAERS: 19
Canada Vigilance: 2		Canada Vigilance
OFFSIDES
US FAERS
12BradycardiaFAERS: 17
Canada Vigilance: 3		153969
15966603		CTD
OFFSIDES
Canada Vigilance
US FAERS
13Device FailureFAERS: 17OFFSIDES
US FAERS
14Blood alkaline phosphatase increasedFAERS: 16US FAERS
15Medication ErrorFAERS: 14
Canada Vigilance: 1		Canada Vigilance
US FAERS
16Cerebral InfarctionFAERS: 11US FAERS
17Deep Vein ThrombosisFAERS: 11US FAERS
18InfectionFAERS: 11US FAERS
19Wrong technique in drug usage processFAERS: 11OFFSIDES
US FAERS
20ChillsFAERS: 10US FAERS
21ErythemaFAERS: 10US FAERS
22No adverse eventFAERS: 10US FAERS
23Needle issueFAERS: 9
Canada Vigilance: 2		Canada Vigilance
US FAERS
24Penile swellingFAERS: 9
Canada Vigilance: 1		Canada Vigilance
OFFSIDES
US FAERS
25Product use issueFAERS: 9US FAERS
26VomitingFAERS: 915966603CTD
US FAERS
27Cerebrovascular accidentFAERS: 8US FAERS
28EnterocolitisFAERS: 815966603CTD
OFFSIDES
US FAERS
29Infantile apnoeic attackFAERS: 8OFFSIDES
US FAERS
30Wrong technique in product usage processFAERS: 8
Canada Vigilance: 2		Canada Vigilance
US FAERS
31Diabetes MellitusFAERS: 7US FAERS
32DiscomfortFAERS: 7US FAERS
33Drug administration errorFAERS: 7OFFSIDES
US FAERS
34Expired product administeredFAERS: 7US FAERS
35Medical device complicationFAERS: 7OFFSIDES
US FAERS
36Neonatal hypotensionFAERS: 7US FAERS
37OverdoseFAERS: 7US FAERS
38Pharmaceutical product complaintFAERS: 7OFFSIDES
US FAERS
39Expired drug administeredFAERS: 6OFFSIDES
US FAERS
40HypersensitivityFAERS: 6US FAERS
41Injection site discomfortFAERS: 6OFFSIDES
US FAERS
42Product label issueFAERS: 6US FAERS
43AnxietyFAERS: 5US FAERS
44Circumstance or information capable of leading to medication errorFAERS: 5
Canada Vigilance: 1		Canada Vigilance
OFFSIDES
US FAERS
45Drug DependenceFAERS: 5US FAERS
46Drug dispensing errorFAERS: 5US FAERS
47Drug prescribing errorFAERS: 5US FAERS
48Foreign body in reproductive tractFAERS: 5
Canada Vigilance: 1		Canada Vigilance
US FAERS
49Injection site injuryFAERS: 5
Canada Vigilance: 1		Canada Vigilance
US FAERS
50Injection site massFAERS: 5US FAERS
51Myocardial InfarctionFAERS: 58961437CTD
US FAERS
52Penile burning sensationFAERS: 5
Canada Vigilance: 1		Canada Vigilance
US FAERS
53Penile curvatureFAERS: 5
Canada Vigilance: 1		Canada Vigilance
US FAERS
54Post procedural complicationFAERS: 5OFFSIDES
US FAERS
55Sexual DysfunctionFAERS: 5US FAERS
56ShockFAERS: 5US FAERS
57ThrombophlebitisFAERS: 512058249CTD
OFFSIDES
US FAERS
58Accidental needle stickFAERS: 4OFFSIDES
US FAERS
59AmnesiaFAERS: 4US FAERS
60Atrioventricular BlockFAERS: 4OFFSIDES
US FAERS
61DyspareuniaFAERS: 4

View details

1296038
1719248
1769856
1875494
1984099
2310934
2686740
3045341
7771004
7966797
8072075
8386779
8677586
8709384
8851852
9288633
9610580
9806184
10098949
10736486
 		CTD
US FAERS
62DysuriaFAERS: 4US FAERS
63Feeding intoleranceFAERS: 4US FAERS
64Foreign body traumaFAERS: 4OFFSIDES
US FAERS
65HeadacheFAERS: 4US FAERS
66Incorrect product storageFAERS: 4US FAERS
67InflammationFAERS: 4US FAERS
68Injection site bruisingFAERS: 4US FAERS
69NecrosisFAERS: 47956562
11317517
15189274		CTD
US FAERS
70PresyncopeFAERS: 4US FAERS
71Product preparation errorFAERS: 4US FAERS
72Product use in unapproved indicationFAERS: 4US FAERS
73Pulmonary EmbolismFAERS: 47740511CTD
US FAERS
74SepsisFAERS: 4US FAERS
75StressFAERS: 4US FAERS
76TachycardiaFAERS: 4
Canada Vigilance: 2		Canada Vigilance
US FAERS
77Therapeutic response unexpectedFAERS: 4US FAERS
78Urethral StenosisFAERS: 4US FAERS
79AmputationFAERS: 3US FAERS
80Atrial FibrillationFAERS: 3US FAERS
81Benign Prostatic HyperplasiaFAERS: 3US FAERS
82Blood glucose increasedFAERS: 3US FAERS
83Chest PainFAERS: 3US FAERS
84Coronary Artery DiseaseFAERS: 3US FAERS
85Device breakageFAERS: 3OFFSIDES
US FAERS
86Device occlusionFAERS: 3US FAERS
87DizzinessFAERS: 39121395CTD
US FAERS
88Emotional distressFAERS: 3US FAERS
89Feeding disorder of infancy OR early childhoodFAERS: 3US FAERS
90Feeling abnormalFAERS: 3US FAERS
91Injury associated with deviceFAERS: 3
Canada Vigilance: 1		Canada Vigilance
US FAERS
92Intentional product misuseFAERS: 3US FAERS
93Intentional product use issueFAERS: 3US FAERS
94Liquid product physical issueFAERS: 3US FAERS
95MalaiseFAERS: 3US FAERS
96Multiple use of single-use productFAERS: 3
Canada Vigilance: 1		Canada Vigilance
US FAERS
97NauseaFAERS: 3US FAERS
98Partner stressFAERS: 3US FAERS
99Patent ductus arteriosusFAERS: 3US FAERS
100Penile operationFAERS: 3OFFSIDES
US FAERS
101Pre-existing condition improvedFAERS: 3US FAERS
102Pulmonary congestionFAERS: 3OFFSIDES
US FAERS
103Sexual relationship changeFAERS: 3US FAERS
104SwellingFAERS: 3US FAERS
105Therapeutic product effect incompleteFAERS: 3
Canada Vigilance: 4		Canada Vigilance
US FAERS
106Urinary RetentionFAERS: 3US FAERS
107Accidental overdoseFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
108ArthralgiaFAERS: 2US FAERS
109BlindnessFAERS: 2US FAERS
110Blood cholesterol increasedFAERS: 2US FAERS
111Blood testosterone decreasedFAERS: 2US FAERS
112Burning sensationFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
113Cardiac ArrestFAERS: 2US FAERS
114DependenceFAERS: 2US FAERS
115Depressed moodFAERS: 2US FAERS
116DisabilityFAERS: 2US FAERS
117EmbolismFAERS: 2US FAERS
118EpilepsyFAERS: 2US FAERS
119Exposure via partnerFAERS: 2US FAERS
120Eye irritationFAERS: 2US FAERS
121Fat necrosisFAERS: 2US FAERS
122FlushingFAERS: 2US FAERS
123GangreneFAERS: 2US FAERS
124HypoxiaFAERS: 210470753CTD
US FAERS
125Incorrect route of drug administrationFAERS: 2US FAERS
126Incorrect storage of drugFAERS: 2US FAERS
127Infusion Site ExtravasationFAERS: 2OFFSIDES
US FAERS
128Joint swellingFAERS: 2US FAERS
129LeukoencephalopathyFAERS: 2US FAERS
130LeukopeniaFAERS: 2US FAERS
131Macular degenerationFAERS: 2US FAERS
132Multiple MyelomaFAERS: 2US FAERS
133Neonatal cardiac failureFAERS: 2OFFSIDES
US FAERS
134PanniculitisFAERS: 2US FAERS
135Penile erythemaFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
136Penile size reducedFAERS: 2US FAERS
137Peripheral arterial occlusive diseaseFAERS: 2OFFSIDES
US FAERS
138PneumoniaFAERS: 2US FAERS
139Poor quality drug administeredFAERS: 2OFFSIDES
US FAERS
140Pregnancy of partnerFAERS: 2US FAERS
141Procedural complicationFAERS: 2US FAERS
142Product prescribing errorFAERS: 2US FAERS
143Product storage errorFAERS: 2US FAERS
144Radical prostatectomyFAERS: 2OFFSIDES
US FAERS
145RhabdomyolysisFAERS: 2US FAERS
146SyncopeFAERS: 2US FAERS
147Transmission of drug via semenFAERS: 2US FAERS
148TremorFAERS: 2US FAERS
149Visual ImpairmentFAERS: 2US FAERS
150Vulvovaginal burning sensationFAERS: 2US FAERS
151Vulvovaginal discomfortFAERS: 2US FAERS
152Weight decreasedFAERS: 2US FAERS
153AbscessFAERS: 1OFFSIDES
US FAERS
154Accidental exposure to productFAERS: 1US FAERS
155Accidental exposureFAERS: 1US FAERS
156Acute left ventricular failureFAERS: 1OFFSIDES
US FAERS
157AlopeciaFAERS: 1US FAERS
158Angina PectorisFAERS: 1US FAERS
159AngioedemaFAERS: 1US FAERS
160Angle Closure GlaucomaFAERS: 1US FAERS
161AnorgasmiaFAERS: 1US FAERS
162AphoniaFAERS: 1US FAERS
163Application site painFAERS: 1OFFSIDES
US FAERS
164ArteriosclerosisFAERS: 1OFFSIDES
US FAERS
165Arthropod stingFAERS: 1US FAERS
166AstheniaFAERS: 1US FAERS
167AtelectasisFAERS: 1US FAERS
168BalanitisFAERS: 1US FAERS
169Blood blisterFAERS: 1OFFSIDES
US FAERS
170Blood creatine increasedFAERS: 1OFFSIDES
US FAERS
171Blood sodium increasedFAERS: 1US FAERS
172Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
173Blue Toe SyndromeFAERS: 1US FAERS
174BronchitisFAERS: 1US FAERS
175Catheter related complicationFAERS: 1US FAERS
176Cerebral disorderFAERS: 1US FAERS
177Chest discomfortFAERS: 1US FAERS
178ColitisFAERS: 1US FAERS
179Contraindicated product administeredFAERS: 1US FAERS
180CystFAERS: 1US FAERS
181Cytomegalovirus test positiveFAERS: 1US FAERS
182DeafnessFAERS: 1US FAERS
183DeformityFAERS: 1US FAERS
184DementiaFAERS: 1US FAERS
185Device defectiveFAERS: 1US FAERS
186Device ineffectiveFAERS: 1US FAERS
187Device related infectionFAERS: 1US FAERS
188Device use issueFAERS: 1US FAERS
189Diabetic FootFAERS: 1US FAERS
190Disease ProgressionFAERS: 1US FAERS
191Disease recurrenceFAERS: 1US FAERS
192DisorientationFAERS: 1US FAERS
193Disseminated Intravascular CoagulationFAERS: 1US FAERS
194Drug administered at inappropriate siteFAERS: 1US FAERS
195Drug dose omissionFAERS: 1US FAERS
196Drug exposure during pregnancyFAERS: 1US FAERS
197Drug ineffective for unapproved indicationFAERS: 1US FAERS
198Drug screen false positiveFAERS: 1US FAERS
199Drug titration errorFAERS: 1US FAERS
200Drug toxicityFAERS: 1US FAERS
201Ductus arteriosus premature closureFAERS: 1US FAERS
202EncephalitisFAERS: 1US FAERS
203EpididymitisFAERS: 1US FAERS
204Feeling jitteryFAERS: 1US FAERS
205FibrosisFAERS: 111549511CTD
US FAERS
206Free fatty acids increasedFAERS: 1US FAERS
207Gastric Antral Vascular EctasiaFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
208Gastrointestinal carcinomaFAERS: 1US FAERS
209General physical health deteriorationFAERS: 1US FAERS
210Genital burning sensationFAERS: 1OFFSIDES
US FAERS
211Genital erythemaFAERS: 1US FAERS
212Genital rashFAERS: 1US FAERS
213Genital swellingFAERS: 1US FAERS
214GlaucomaFAERS: 1US FAERS
215Hepatic Vein ThrombosisFAERS: 1US FAERS
216HypertrichosisFAERS: 1OFFSIDES
US FAERS
217Hypocoagulable stateFAERS: 1US FAERS
218Hypoplastic Left Heart SyndromeFAERS: 1US FAERS
219Hypothalamo-pituitary disorderFAERS: 1US FAERS
220HypoventilationFAERS: 1US FAERS
221Infusion site erythemaFAERS: 1US FAERS
222Injection Site ReactionFAERS: 1US FAERS
223Injection site abscessFAERS: 1US FAERS
224Injection site erythemaFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
225Injection site irritationFAERS: 1OFFSIDES
US FAERS
226Injection site phlebitisFAERS: 1US FAERS
227Intentional drug misuseFAERS: 1OFFSIDES
US FAERS
228Intentional misuseFAERS: 1US FAERS
229Intentional self-injuryFAERS: 1US FAERS
230KeratorhexisFAERS: 1US FAERS
231Libido disorderFAERS: 1US FAERS
232LymphadenopathyFAERS: 1US FAERS
233Maternal exposure during pregnancyFAERS: 1US FAERS
234MetastasisFAERS: 1US FAERS
235Mitral Valve StenosisFAERS: 1US FAERS
236Muscle CrampFAERS: 1US FAERS
237Musculoskeletal discomfortFAERS: 1US FAERS
238MyocarditisFAERS: 1US FAERS
239Neck PainFAERS: 1US FAERS
240Neonatal disorderFAERS: 1US FAERS
241No reaction on previous exposure to drugFAERS: 1US FAERS
242Ocular discomfortFAERS: 1US FAERS
243OrchitisFAERS: 1US FAERS
244PCO2 increasedFAERS: 1US FAERS
245PO2 decreasedFAERS: 1OFFSIDES
US FAERS
246Painful ejaculationFAERS: 1US FAERS
247ParaplegiaFAERS: 1US FAERS
248PemphigusFAERS: 1US FAERS
249Penile contusionFAERS: 1US FAERS
250PeriostitisFAERS: 1US FAERS
251Peripheral swellingFAERS: 1US FAERS
252PhimosisFAERS: 1US FAERS
253Pneumatosis intestinalisFAERS: 1US FAERS
254PolyneuropathyFAERS: 1US FAERS
255PolyuriaFAERS: 1US FAERS
256Prescription drug used without a prescriptionFAERS: 1US FAERS
257Product complaintFAERS: 1
Canada Vigilance: 6		Canada Vigilance
US FAERS
258Product contamination microbialFAERS: 1US FAERS
259Product leakageFAERS: 1US FAERS
260Product packaging issueFAERS: 1US FAERS
261Product packaging quantity issueFAERS: 1US FAERS
262Product physical issueFAERS: 1US FAERS
263Product preparation issueFAERS: 1US FAERS
264Product sterility lackingFAERS: 1US FAERS
265ProstatectomyFAERS: 1US FAERS
266Pseudo-Bartter syndromeFAERS: 1US FAERS
267Pulmonary granulomaFAERS: 1US FAERS
268PurulenceFAERS: 1OFFSIDES
US FAERS
269Pustular psoriasisFAERS: 1US FAERS
270RalesFAERS: 1US FAERS
271Respiratory FailureFAERS: 1US FAERS
272Respiratory arrestFAERS: 1US FAERS
273RhabdomyomaFAERS: 1US FAERS
274Right Ventricular HypertrophyFAERS: 1US FAERS
275Right ventricle outflow tract obstructionFAERS: 1US FAERS
276Sexual abuseFAERS: 1US FAERS
277Shunt malfunctionFAERS: 1US FAERS
278Skin UlcerFAERS: 13619123CTD
US FAERS
279Skin lesionFAERS: 1US FAERS
280Supraventricular tachycardiaFAERS: 1OFFSIDES
US FAERS
281Suspected counterfeit productFAERS: 1US FAERS
282Syringe issueFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
283Therapeutic product contaminationFAERS: 1US FAERS
284ThrombocytopeniaFAERS: 12306970CTD
US FAERS
285Thrombosis in deviceFAERS: 1US FAERS
286ThrombosisFAERS: 1US FAERS
287Thyroid NeoplasmFAERS: 1US FAERS
288Troponin increasedFAERS: 1US FAERS
289Unevaluable eventFAERS: 1US FAERS
290Urethritis noninfectiveFAERS: 1US FAERS
291Urinary tract infectionFAERS: 1US FAERS
292Urine flow decreasedFAERS: 1US FAERS
293Uterine RuptureFAERS: 1US FAERS
294Vascular device infectionFAERS: 1US FAERS
295Vascular dissectionFAERS: 1US FAERS
296VasculitisFAERS: 1US FAERS
297Venous ThrombosisFAERS: 1US FAERS
298Vulvovaginal injuryFAERS: 1US FAERS
299Vulvovaginal pruritusFAERS: 1US FAERS
300Wrong drug administeredFAERS: 1US FAERS
301prostatitisFAERS: 1US FAERS
302Abdominal discomfortOFFSIDES
303AcidosisOFFSIDES
304Acute kidney injury1102487
10420905		CTD
305Aneurysm8115269CTD
306Apnea15966603CTD
OFFSIDES
307Application site erythemaOFFSIDES
308Arterial Occlusive Diseases3619123
8044953		CTD
309Arteriosclerosis ObliteransOFFSIDES
310Atherosclerosis obliteransOFFSIDES
311Blood creatinine decreasedOFFSIDES
312Blood pH decreasedOFFSIDES
313Blood potassium decreasedOFFSIDES
314Body TemperatureOFFSIDES
315BursitisOFFSIDES
316Cancer PainOFFSIDES
317Carotid Artery ThrombosisOFFSIDES
318Catalepsy11519
3862460
6679984		CTD
319Cauda Equina SyndromeOFFSIDES
320Cerebral Hemorrhage11310497CTD
321Chemical and Drug Induced Liver Injury2329724
9365130		CTD
322Cholestasis2329724CTD
323Chronic left ventricular failureOFFSIDES
324Congenital tricuspid valve incompetenceOFFSIDES
325Coronary Stenosis3421167CTD
326Cystitis viralOFFSIDES
327Deafness NeurosensoryOFFSIDES
328Decreased LibidoOFFSIDES
329Depressive disorder2875251CTD
330Disease complicationOFFSIDES
331Drug abuseCanada Vigilance: 1Canada Vigilance
332Duodenal UlcerOFFSIDES
333Dysarthria7824478CTD
334Dyskinesia, Drug-Induced3862460CTD
335Dyspnea7282515CTD
336Edema11549511CTD
337Ejection Fraction DecreasedOFFSIDES
338Endotoxic shockOFFSIDES
339Eosinophil percentage increasedOFFSIDES
340Eosinophilic myocarditisOFFSIDES
341Erythema MultiformeOFFSIDES
342Exanthema15966603CTD
343Fatty Liver10221824CTD
344Fetal Death10826591CTD
345Fever15966603CTD
346Gastrointestinal Diseases1613947CTD
347Glomerulonephritis7028332CTD
348Graft dysfunctionOFFSIDES
349HaematotoxicityOFFSIDES
350Heart failure7282515
16084762		CTD
351Heart-lung transplant rejectionOFFSIDES
352Hematoma8821692
10098949		CTD
353HepatectomyOFFSIDES
354Hepatic artery stenosisOFFSIDES
355HiccoughOFFSIDES
356Hyperalgesia

View details

6304817
7830882
8907337
10481416
 		CTD
357HypercapniaOFFSIDES
358Impotence, Vasculogenic1719248
2038782
11248634		CTD
359Incisional herniaOFFSIDES
360Injection site dischargeCanada Vigilance: 1Canada Vigilance
361Injection site inflammationOFFSIDES
362Ischemia3619123
8529683		CTD
363Liver diseases9088814CTD
364Low Cardiac Output SyndromeOFFSIDES
365Lymphatic Diseases7028332CTD
366Lymphatic duct ruptureOFFSIDES
367LymphomaOFFSIDES
368Lymphoplasmacytoid lymphoma/immunocytomaOFFSIDES
369Markedly reduced dietary intakeOFFSIDES
370Motor retardationOFFSIDES
371Mucocutaneous Lymph Node Syndrome8529683CTD
372Muscle necrosisOFFSIDES
373Myocardial Ischemia1575347
10826591		CTD
374Myoglobin blood increasedOFFSIDES
375NephroangiosclerosisOFFSIDES
376Neuroblastoma recurrentOFFSIDES
377Neutropenic infectionOFFSIDES
378OliguriaOFFSIDES
379Open woundOFFSIDES
380Oropharyngeal painOFFSIDES
381Pancreas lipomatosisOFFSIDES
382Pancreatic enzymes increasedOFFSIDES
383Paraesthesia of genital maleOFFSIDES
384Penile InfectionOFFSIDES
385Phlebitis10999612CTD
386PleurisyOFFSIDES
387Polyarteritis Nodosa16435120CTD
388Portal Vein ThrombosisOFFSIDES
389Postoperative Complications2009800
3860879
11317517		CTD
390Product administration errorCanada Vigilance: 1Canada Vigilance
391Product physical consistency issueCanada Vigilance: 1Canada Vigilance
392Product reconstitution quality issueCanada Vigilance: 2Canada Vigilance
393Pulmonary InfarctionOFFSIDES
394Raynaud Disease11310497CTD
395Renal cystOFFSIDES
396Respiratory Distress Syndrome, Adult10470753CTD
397Retrograde amnesiaOFFSIDES
398RhonchiOFFSIDES
399Skin Diseases, Vascular1410981CTD
400Sputum culture positiveOFFSIDES
401Tetralogy of Fallot3543871CTD
402Therapeutic product effect decreasedCanada Vigilance: 3Canada Vigilance
403Therapeutic product effect variableCanada Vigilance: 1Canada Vigilance
404Therapy non-responderOFFSIDES
405Thermal burnCanada Vigilance: 1Canada Vigilance
406Thromboangiitis Obliterans11598405CTD
407Troponin I increasedOFFSIDES
408Unresponsive to verbal stimuliOFFSIDES
409Upper respiratory tract inflammationOFFSIDES
410Urine osmolarity increasedOFFSIDES
411Vaginal DischargeCanada Vigilance: 1Canada Vigilance
412Vascular calcificationOFFSIDES
413Vena cava filter insertionOFFSIDES
414Ventricular FibrillationOFFSIDES
415Weight decrease neonatalOFFSIDES
416Wheelchair userOFFSIDES
417treatment failureOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.